The Medical Research Future Fund (MRFF) has recently been awarded $40 million funding to Brandon Capital Partners’ Medical Research Commercialisation Fund (MRCF).  MRCF has established CUREator to provide funding to support two streams of early stage Australian medical research translation and commercialisation.

Stream 1: preclinical biomedical projects with commercial potential.  CUREator’s aim is to fund at least 25 projects over 3 years providing $500k-$1m per project to develop the product opportunity to a point that it is ready for venture capital investment.

Stream 2: early clinical development of novel drugs, or novel uses for existing drugs, with commercial potential.  CUREator’s aim is to fund at least 11 projects with up to $1.5m per project over 3 years.  Stream 2 projects will be matched 1:1 with venture capital from the MRCF.

Researchers are cordially invited to attend an information session with Dr Goslik Schepers, Senior Investment Manager, Brandon Capital Partners Pty Ltd when he will provide additional information on CUREator and the application process.

Expressions of Interests (EOIs) for Round 1 opened on 11 November and close on 6 December 2021 at 3:00pm AEST.

Don’t miss this information session to find out more!

If you are a UQ agriculture or food science researcher join us to hear advice from presenters on how to position your research to attract industry partners including investors.  You will also hear how to look at the market place and the value chain, identify what you have and who may see value in it.

As a business providing consulting and contract research services to agriculture and food companies, Colere has experience in engaging with the agricultural industry and how to frame science to meet the needs of industry.

Uniseed is Australia’s longest running venture fund operating at the Universities of Melbourne, Queensland, Sydney and New South Wales, and CSIRO.

UQ researchers are invited to attend a workshop with venture investors, IP Group.  Join us to understand how your research could attract venture capital into an exciting new start-up company!

In this interactive workshop, the IP Group team of Dr Siro Perez and Dr David Hemmi will discuss how they work with UniQuest and researchers to evaluate technologies for investments and shed light on how the start-up journey might look like by sharing case studies from their Australian portfolio and taking questions from researchers.

IP Group are interested in technologies ranging from agriculture, therapeutics and medical devices, all the way to digital and engineering breakthroughs.

Over the past 20 years, IP Group has created more than 150 companies based on world-leading research from its international university partners. In Australia, IP Group have already invested in 13 science-based companies and are looking for more.